Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.71% | -8.80% | -8.21% | -6.96% | 35.57% |
| Total Receivables | -13.40% | -13.59% | -1.24% | 15.43% | 20.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.04% | -27.07% | 47.29% | -27.48% | -25.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 1,004.92% | -83.99% | 0.00% | -84.13% |
| Total Current Assets | -18.20% | -8.72% | -7.29% | -7.03% | 28.67% |
|
|
|||||
| Total Current Assets | -18.20% | -8.72% | -7.29% | -7.03% | 28.67% |
| Net Property, Plant & Equipment | -10.36% | -8.33% | -8.38% | -7.92% | -7.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -18.03% | -8.71% | -7.31% | -7.05% | 27.62% |
|
|
|||||
| Total Accounts Payable | 23.40% | 18.45% | 117.76% | -56.63% | -56.62% |
| Total Accrued Expenses | 78.50% | 84.66% | -6.34% | 75.92% | -31.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.08% | -1.89% | 2.65% | 2.16% | 1.65% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 59.52% | 54.55% | 15.13% | 10.58% | -42.85% |
|
|
|||||
| Total Current Liabilities | 59.52% | 54.55% | 15.13% | 10.58% | -42.85% |
| Long-Term Debt | 1.75% | 1.75% | 1.75% | 1.75% | 1.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.27% | -12.77% | -13.32% | -11.49% | -10.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.07% | 6.23% | 2.52% | 2.09% | -4.06% |
|
|
|||||
| Common Stock & APIC | 0.46% | 0.46% | 0.45% | 0.44% | 9.81% |
| Retained Earnings | -5.65% | -3.48% | -2.73% | -2.78% | -3.18% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 9.53% |
| Total Common Equity | -146.57% | -45.25% | -24.91% | -19.90% | 138.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -146.57% | -45.25% | -24.91% | -19.90% | 138.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -146.57% | -45.25% | -24.91% | -19.90% | 138.04% |
|
|
|||||